Specialty medical injectable drug program, requirements and drug policy updates: Skyrizi®
New specialty medical injectable updates and requirements announced.
Aug. 26, 2022
- All states
Please review the following table to determine changes to our specialty medical injectable drug programs.
|Drug Name||UnitedHealthcare Commercial||Treatment Uses|
|X||New formulation and dosage, used to treat adults with moderate to severe Crohn’s disease.|
Review the UnitedHealthcare Commercial Plan Review at Launch Medication List.
For questions, please contact your broker or UnitedHealthcare representative.
More updates for your clients
New releases, updates and notifications for a broad spectrum of UnitedHealthcare products and services.